Lader Joshua M, Barbhaiya Chirag R, Subnani Kishore, Park David, Aizer Anthony, Holmes Douglas, Staniloae Cezar, Williams Mathew R, Chinitz Larry A
Departments of Medicine, New York University School of Medicine, New York, New York.
Cardiothoracic Surgery, New York University School of Medicine, New York, New York.
Pacing Clin Electrophysiol. 2019 Oct;42(10):1347-1354. doi: 10.1111/pace.13789. Epub 2019 Sep 5.
A common complication of transcatheter aortic valve repair (TAVR) is development of conduction defects requiring pacemaker (PPM) implantation. These defects are not universally permanent.
To determine the incidence and predictors of persistent device dependency in patients with PPM implantation following TAVR with a self-expanding prosthesis.
Records of patients who underwent post-TAVR PPM implantation were reviewed. Patients with persistent complete AV block (AVBIII) one month post-TAVR were compared to those regaining conduction.
Between September 2014 and March 2017, 485 patients underwent TAVR with a self-expanding prosthesis; 77 (15.9%) underwent PPM implantation for AVBIII. Device interrogation at one month was available for 61 patients (79%): 22 (36.1%) had resolution of AVBIII while 39 (63.9%) remained pacemaker-dependent. Pre-TAVR right bundle branch block was more frequent in device-dependent patients (19 of 38, 50% vs 4 of 22, 18%; RR 2.75; P = .01). Device-dependence was associated with AVBIII as the first postprocedural rhythm (37 of 39, 95% vs 12 of 22, 55%; RR 1.74; P < .0001), earlier implantation (median 1d, IQR: 0-1.5d vs 2d, IQR: 1.0-4.0d, P = .0004), and a shorter duration of hospitalization (median 3d, IQR: 2-3.5d vs 4d, IQR: 2-5.75d, P = .03). Pacemaker dependence was also associated with a higher prosthesis-to left ventricular outflow tract (LVOT) diameter (1.45 ± 0.11 vs 1.39 ± 0.07; P = .02) and the lack of prior aortic valvuloplasty (5 of 39, 13% vs 8 of 22, 36%; RR 0.35; P = .03).
In patients receiving a PPM following self-expanding TAVR, a long-term pacing requirement can be predicted from the timing of AV block, existing conduction-system disease, larger prosthesis-to-LVOT diameter, and the lack of aortic valvuloplasty.
经导管主动脉瓣修复术(TAVR)的一种常见并发症是发生传导缺陷,需要植入起搏器(PPM)。这些缺陷并非普遍永久性的。
确定接受自膨胀式人工瓣膜TAVR术后植入PPM的患者持续依赖器械的发生率及预测因素。
回顾接受TAVR术后植入PPM患者的记录。将TAVR术后1个月仍存在持续性完全性房室传导阻滞(AVBIII)的患者与恢复传导的患者进行比较。
2014年9月至2017年3月期间,485例患者接受了自膨胀式人工瓣膜TAVR;77例(15.9%)因AVBIII接受了PPM植入。61例患者(79%)有术后1个月的器械检测数据:22例(36.1%)AVBIII消失,39例(63.9%)仍依赖起搏器。术前右束支传导阻滞在依赖器械的患者中更常见(38例中的19例,50% vs 22例中的4例,18%;RR 2.75;P = 0.01)。器械依赖与术后首个心律为AVBIII相关(39例中的37例,95% vs 22例中的12例,55%;RR 1.74;P < 0.0001)、更早植入(中位数1天,IQR:0 - 1.5天 vs 2天,IQR:1.0 - 4.0天,P = 0.0004)以及住院时间较短(中位数3天,IQR:2 - 3.5天 vs 4天,IQR:2 - 5.75天,P = 0.03)。起搏器依赖还与更大的人工瓣膜与左心室流出道(LVOT)直径相关(1.45 ± 0.11 vs 1.39 ± 0.07;P = 0.02)以及缺乏既往主动脉瓣球囊成形术相关(39例中的5例,13% vs 22例中的8例,36%;RR 0.35;P = 0.03)。
在接受自膨胀式TAVR术后植入PPM的患者中,房室传导阻滞的时间、现有的传导系统疾病、更大的人工瓣膜与LVOT直径以及缺乏主动脉瓣球囊成形术可预测长期起搏需求。